{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:28:58Z","timestamp":1780482538555,"version":"3.54.1"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>HFE hemochromatosis is characterized by increased iron absorption and iron overload due to variants of the iron-regulating HFE gene. Overt disease is mainly associated with homozygosity for the C282Y variant, although the H63D variant in compound heterozygosity with C282Y (C282Y\/H63D) contributes to disease manifestation. In this observational study, we describe the association between biochemical findings, age, gender and HFE genotype in patients referred from general practice to a tertiary care referral center for diagnostic workup based on suspected hemochromatosis due to persistent hyperferritinemia and HFE variants. C282Y and H63D homozygosity were, respectively, the most and least prevalent genotypes and we found a considerable variation in transferrin saturation and ferritin levels independent of HFE genotype, which may indeed represent a diagnostic challenge in general practice. While our results confirm C282Y homozygosity as the major cause of iron accumulation, non-C282Y homozygotes also displayed mild to moderate hyperferritinemia with median ferritin levels at 500\u2013700 \u00b5g\/L, well above the reference cut-off. Such findings have traditionally been ignored in the clinic, and initiation of iron depletion has largely been restricted to C282Y homozygotes. Nevertheless, superfluous iron can aggravate pathogenesis in combination with other diseases and risk factors, such as inflammation, cancer and hepatopathy, and this possibility should not be neglected by clinicians.<\/jats:p>","DOI":"10.3390\/genes12081162","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T21:21:04Z","timestamp":1627507264000},"page":"1162","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis"],"prefix":"10.3390","volume":"12","author":[{"given":"Miriam","family":"Sandnes","sequence":"first","affiliation":[{"name":"Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vorland","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics, Haukeland University Hospital, N-5021 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6385-296X","authenticated-orcid":false,"given":"Rune J.","family":"Ulvik","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-8411","authenticated-orcid":false,"given":"H\u00e5kon","family":"Reikvam","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway"},{"name":"Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I\u2013like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jmg.34.4.275","article-title":"Global prevalence of putative haemochromatosis mutations","volume":"34","author":"Pointon","year":"1997","journal-title":"J. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(99)70244-1","article-title":"Molecular medicine and hemochromatosis: At the crossroads","volume":"116","author":"Bacon","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/aje\/154.3.193","article-title":"HFE gene and hereditary hemochromatosis: A HuGE review. Human Genome Epidemiology","volume":"154","author":"Hanson","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron\u2013overload\u2013related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G\u2192A (C282Y) HFE hereditary haemochromatosis mutation in the USA","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/003655201750422747","article-title":"Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons","volume":"36","author":"Hveem","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/GIM.0b013e31819d30f2","article-title":"HFE\u2013associated hereditary hemochromatosis","volume":"11","author":"Alexander","year":"2009","journal-title":"Genet. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(07)61782-6","article-title":"Haemochromatosis","volume":"370","author":"Adams","year":"2007","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and iron\u2013overload screening in a racially diverse population","volume":"352","author":"Adams","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","article-title":"Serum ferritin: Past, present and future","volume":"1800","author":"Wang","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1053\/j.gastro.2008.08.056","article-title":"The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis","volume":"135","author":"Gurrin","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0016-5085(98)70538-4","article-title":"Distribution of transferrin saturation in an Australian population: Relevance to the early diagnosis of hemochromatosis","volume":"114","author":"McLaren","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2011.05.008","article-title":"Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target","volume":"55","author":"Dongiovanni","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sandnes, M., Ulvik, R.J., Vorland, M., and Reikvam, H. (2021). Hyperferritinemia\u2014A Clinical Overview. J. Clin. Med., 10.","DOI":"10.3390\/jcm10092008"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/gim.2017.121","article-title":"Clinical penetrance in hereditary hemochromatosis: Estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes","volume":"20","author":"Grosse","year":"2018","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJM199306033282208","article-title":"Screening for hemochromatosis","volume":"328","author":"Edwards","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/jhep.2002.35343","article-title":"Noninvasive prediction of cirrhosis in C282Y\u2013linked hemochromatosis","volume":"36","author":"Beaton","year":"2002","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood-2007-07-102673","article-title":"Screening for hemochromatosis by measuring ferritin levels: A more effective approach","volume":"111","author":"Waalen","year":"2008","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG Clinical Guideline: Hereditary Hemochromatosis","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver (2010). EASL clinical practice guidelines for HFE hemochromatosis. J. Hepatol., 53, 3\u201322.","DOI":"10.1016\/j.jhep.2010.03.001"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00365510903527838","article-title":"Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation","volume":"70","author":"Thorstensen","year":"2010","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Barton, J.C., and Edwards, C.Q. (2000). The iron phenotype of hemochromatosis heterozygotes. Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment, Cambridge University Press.","DOI":"10.1017\/CBO9780511666476"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: More ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.nutr.012809.104804","article-title":"Iron homeostasis and the inflammatory response","volume":"30","year":"2010","journal-title":"Annu. Rev. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12072-008-9076-z","article-title":"The effect of iron depletion on chronic hepatitis C virus infection","volume":"2","author":"Franchini","year":"2008","journal-title":"Hepatol. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12026-020-09145-5","article-title":"COVID\u201319 as part of the hyperferritinemic syndromes: The role of iron depletion therapy","volume":"68","author":"Perricone","year":"2020","journal-title":"Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.12659\/MSM.896494","article-title":"The Role of Iron and Iron Overload in Chronic Liver Disease","volume":"22","author":"Milic","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.3748\/wjg.v13.i37.4925","article-title":"Role of alcohol in the regulation of iron metabolism","volume":"13","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Zecca","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2003-10-3366","article-title":"HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype","volume":"103","author":"Jacolot","year":"2004","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/hmg\/ddg225","article-title":"Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis","volume":"12","author":"Cadet","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(02)11607-2","article-title":"Genetics of haemochromatosis","volume":"360","author":"Bomford","year":"2002","journal-title":"Lancet"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/8\/1162\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:36:29Z","timestamp":1760164589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/8\/1162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["genes12081162"],"URL":"https:\/\/doi.org\/10.3390\/genes12081162","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]}}}